Author

K. Röltgen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Kundaje· 1 shared B. A. Pinsky· 1 shared B. F. Haynes· 1 shared B. J. Ward· 1 shared B. Lam· 1 shared B. Pulendran· 1 shared C. A. Blish· 1 shared C. Cunningham-Rundles· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Kundaje

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Disease diagnostics using machine learning of immune receptors

M. E. Zaslavsky, E. Craig, J. K. Michuda, N. Sehgal, N. Ram-Mohan, J.-Y. Lee, K. D. Nguyen, R. A. Hoh, T. D. Pham, K. Röltgen, B. Lam, E. S. Parsons, S. R. Macwana, W. DeJager, E. M. Drapeau, , S. D. Boyd

The paper develops Mal-ID, a machine learning framework using immune receptor data to diagnose diseases, detecting infections, autoimmune disorders, and vaccine responses.

bioRxiv · Apr 26, 2022Immunology

Safety, immunogenicity and protection provided by unadjuvanted and adjuvanted formulations of recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in non-human primates

S. Pillet, P. S. Arunachalam, G. Andreani, N. Golden, J. Fontenot, P. Aye, K. Röltgen, G. Lehmick, C. Dube, P. Gobeil, S. Trepanier, N. Charland, M.-A. D'Aoust, K. Russell-Lodrigue, R. V. Blair, , N. Landry

This study evaluates the safety and immunogenicity of a plant-derived VLP vaccine against SARS-CoV-2 in non-human primates, finding that AS03 adjuvanted vaccine provides better protection and immune response.

bioRxiv · May 15, 2021Immunology